(Q34379322)

1 August 2017

title

Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

10

Anne B Chang

1 reference

1 August 2017

Gabrielle B McCallum

8

0 references

Catherine A. Byrnes

object named as

Catherine A Byrnes

5

0 references

Patricia C Valery

object named as

Patricia C Valery

1

0 references

Keith Grimwood

3

0 references

Paul J Torzillo

4

object named as

Paul J Torzillo

1 reference

1 August 2017

6

I Brent Masters

1 reference

1 August 2017

Peter S Morris

2

1 reference

1 August 2017

Paul A Bauert

7

1 reference

1 August 2017

Charmaine Mobberly

9

1 reference

1 August 2017

publication date

14 August 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

page(s)

122

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

copyright license

start time

14 August 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Macrolide antibiotics for cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Chronic respiratory symptoms and diseases among indigenous children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Mortality in bronchiectasis: a long-term study assessing the factors influencing survival

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Management of bronchiectasis and chronic suppurative lung disease in indigenous children and adults from rural and remote Australian communities

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Exacerbations in cystic fibrosis: 4--Non-cystic fibrosis bronchiectasis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Prolonged antibiotics for purulent bronchiectasis in children and adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Azithromycin and lower respiratory tract infections.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

New Zealand national incidence of bronchiectasis "too high" for a developed country.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Assessment of airway neutrophils by sputum colour: correlation with airways inflammation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Anti-inflammatory activity of macrolide antibiotics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

The macrolides: erythromycin, clarithromycin, and azithromycin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Inflammation: a two-edged sword--the model of bronchiectasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3445847

Non-CF bronchiectasis: clinical and HRCT evaluation

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Trends in bronchiectasis mortality in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Early radiographic and clinical features associated with bronchiectasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Airway microbiology and host defences in paediatric non-CF bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Assessing response to treatment of exacerbations of bronchiectasis in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Macrolides Inhibit Epithelial Cell–Mediated Neutrophil Survival by Modulating Granulocyte Macrophage Colony–Stimulating Factor Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Macrolide resistance among invasive Streptococcus pneumoniae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Quality-of-life determinants in patients with clinically stable bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Hospital-Based Case-Control Study of Bronchiectasis in Indigenous Children in Central Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Respiratory Bacterial Pathogens in the Nasopharynx and Lower Airways of Australian Indigenous Children with Bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2431-12-122

Computed tomography of bronchiectasis

21 January 2018

1 reference

12 December 2020

The response of patients with purulent bronchiectasis to antibiotics for four months

1 reference

12 December 2020

Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis

1 reference

12 December 2020

Bronchiectasis in Alaska Native children: causes and clinical courses

1 reference

12 December 2020

Bronchiectasis: causes and management

1 reference

12 December 2020

Bronchiectasis: still a problem

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2431-12-122

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference